ReviewInternational journal of molecular sciences2026
Microarray-Based Genomic Profiling in Low-Dose Radiation Research: Evidence, Limitations, and Translational Perspectives.
Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Low-dose ionizing radiation exposure remains a major challenge for long-term health risk assessment, particularly in retrospective cohorts with heterogeneous exposure scenarios and limited biological material. Although next-generation sequencing (NGS) technologies dominate contemporary molecular research, DNA microarrays remain relevant in radiation biology due to their standardization, reproducibility, cost-effectiveness, and compatibility with archived biospecimens. This narrative review examines the contribution of microarray-based transcriptomic and epigenomic profiling to the study of low-dose radiation effects (≤100 mSv, millisievert), with emphasis on human observational studies, radiation epidemiology, and biodosimetric applications. The literature was identified through targeted searches in PubMed and Web of Science (2000-2025). Evidence from experimental models and exposed populations is synthesized to identify recurrent molecular pathways, major sources of variability, and challenges affecting reproducibility and cross-cohort comparability. Based on this evidence, a conceptual framework is proposed to define conditions under which microarray-based analyses remain interpretable and translationally informative. Machine learning approaches are discussed in a supportive role, with emphasis on interpretability and biological plausibility. Overall, DNA microarrays are positioned as a mature, niche technology that complements next-generation sequencing platforms and remains particularly suited for retrospective cohort studies and long-term molecular monitoring in radiation research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.